Cargando…
Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis
BACKGROUND: Synthetic cannabinoids (SCs) are a class of new psychoactive substances that have been rapidly evolving around the world throughout recent years. Many different synthetic cannabinoid analogues are on the consumer market and sold under misleading names, like “spice” or “incense.” A limite...
Autores principales: | Mensen, Vincent T., Vreeker, Annabel, Nordgren, Johan, Atkinson, Amanda, de la Torre, Rafael, Farré, Magi, Ramaekers, Johannes G., Brunt, Tibor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695363/ https://www.ncbi.nlm.nih.gov/pubmed/30968175 http://dx.doi.org/10.1007/s00213-019-05238-8 |
Ejemplares similares
-
Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020) -
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
por: Craft, Sam, et al.
Publicado: (2021) -
A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022) -
Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
por: Theunissen, Eef L., et al.
Publicado: (2021) -
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)